Science-driven commentary on drug discovery, therapeutic innovation, and the evolving landscape of the biopharmaceutical industry.
Could lifestyle changes replace GLP-1 medications like Wegovy or Zepbound? Dr. Jedinak shares his personal 30-pound weight-loss journey and the science behind insulin sensitivity and cortisol balance — and why 15–20 minutes of light exercise a day may outperform semaglutide.
✍️ Andrej Jedinak, PhD · June 30, 2026
Topics in immuno-oncology, checkpoint biology, and tumor microenvironment research. Subscribe below to be notified.
Articles on pharmacology strategy, target validation approaches, and translational science best practices.
Perspectives on rare disease drug development, orphan designations, and patient-centric development strategies.
Subscribe to receive new articles and insights directly in your inbox — no spam, unsubscribe anytime.
No spam. Scientific insights only. Unsubscribe anytime.